BioSpace News Archive

Deals

Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. and Amryt Pharma Plc announced that the companies have entered into a definitive agreement under which Chiesi will acquire Amryt.

January 8, 2023
·
12 min read
Business

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Exact Sciences Corp. announced that the company expects to report revenue between $550.7 million and $552.7 million for the fourth quarter ended Dec. 31, 2022.

January 8, 2023
·
10 min read
Business

Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022

Akoya Biosciences, Inc., The Spatial Biology Company®, announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2022.

January 8, 2023
·
3 min read
Business

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results

RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2022.

January 8, 2023
·
4 min read
Business

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023

Hologic, Inc. announced preliminary revenue results for its first fiscal quarter ended December 31, 2022.

January 8, 2023
·
12 min read
Business

Exelixis Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results, Provides 2023 Financial Guidance, and Outlines Key Priorities and Milestones for 2023

Exelixis, Inc. announced its preliminary unaudited financial results for the fourth quarter and full year 2022, provided financial guidance for full year 2023, and delivered an update on its business.

January 8, 2023
·
21 min read
Drug Development

Day One Announces Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma

Day One Biopharmaceuticals announced positive topline results from the ongoing, open-label, pivotal Phase 2 FIREFLY-1 trial evaluating the investigational agent, tovorafenib, as a monotherapy in recurrent or progressive pediatric low-grade glioma.

January 8, 2023
·
8 min read
Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference

Ascendis Pharma A/S provided an update on its Vision 3x3 strategic roadmap and planned 2023 key corporate milestones.

January 8, 2023
·
8 min read
Business

Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

Telix Pharmaceuticals Limited advises it is presenting at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco.

January 8, 2023
·
4 min read
IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S

IMV Inc., a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, outlined its planned 2023 milestones to advance the clinical development of its lead therapeutic, maveropepimut-S.

January 8, 2023
·
7 min read